Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....

To Date: 03/08/2026 Department of Corporate Affairs- Listing, BSE Limited, Phiroz Jee Jeebhoy Towers, Dalal Street, Fort Mumbai-400001. Scrip Code: 530313 [KIMIABL] Sub: Regulation 29 of SEBI (LODR) Regulations, 2015 –Intimation of Meeting of Board of Directors. Dear Sir, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Monday, August 10, 2026, inter alia, to consider & approve the Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th, 2026. Further, In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) has already been closed w.e.f. 1st July, 2026 up to the completion of 48 hours after the declaration of unaudited Financial Results for the 1st quarter ended 30th June 2026 to the Stock Exchange. Kindly take the above information on your record. Thanking You, Yours faithfully, For KIMIA BIOSCIENCES LIMITED Abhishek Kumar Pandey Company Secretary & Compliance Officer M. No. F12457 Place: New Delhi KIMIA BIOSCIENCES LIMITED Regd. Office/Works Corporate Office Village Bhondsi, Damdama Lake Road, 974, 9" Floor, Aggarwal Millennium Tower-II Gu rug ram, Haryana-122102 Netaji Subhash Place, Pitampura, New Delhi-110034, INDIA Tel.: +91 9654746544, 9654206544 Tel.: +91 11 47063600, 470630601 compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120